Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074133 · ClinicalTrials.gov registry record
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
A clinical trial of Pulmonary Nodule, sponsored by Vanderbilt-Ingram Cancer Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 4
- Study locations
NCT06074133: Recruiting study of Pulmonary Nodule, sponsored by Vanderbilt-Ingram Cancer Center.
NCT06074133 is a study of Pulmonary Nodule that is actively recruiting participants, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 100 participants, below the 338-participant average among 4 other Pulmonary Nodule trials with a reported enrollment target (70% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06074133, a study of Pulmonary Nodule, is actively recruiting participants, sponsored by Vanderbilt-Ingram Cancer Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.
Conditions Studied
Interventions
- PROCEDURE Blood collection
- PROCEDURE Chest Computed Tomography
Study Locations (4)
Colorado
- Rocky Mountain Regional VA Medical Center - Aurora
- University of Colorado - Aurora
Tennessee
- Vanderbilt University/Ingram Cancer Center - Nashville
- VA Tennessee Valley Healthcare Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2029-03-31 |
What NCT06074133 shows while recruiting
NCT06074133 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 338-participant average among 4 other Pulmonary Nodule trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Pulmonary Nodule appearing as the primary indexed condition, and to 2 interventions - of which Blood collection is the first listed.
NCT06074133 reports a single indexed study location in Colorado, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06074133 about?
NCT06074133 is a clinical study titled "A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules". This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.
What is the current status of trial NCT06074133?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-03-07. Estimated completion is 2029-03-31.
What conditions does trial NCT06074133 study?
This clinical trial studies the following conditions: Pulmonary Nodule.
What interventions are being tested in trial NCT06074133?
The interventions under investigation include: Blood collection (PROCEDURE), Chest Computed Tomography (PROCEDURE).
Who is sponsoring clinical trial NCT06074133?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06074133 being conducted?
This trial has 4 study locations across Colorado, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Nodule
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Utility for Ion Endoluminal System
ACTIVE NOT RECRUITING · NA
-
Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung
COMPLETED
-
A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions
COMPLETED
-
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI